News
Blood clots are a silent threat behind many serious illnesses—from sepsis and cancer to viral infections and autoimmune disease. Now, inventors at the NIH National Cancer Institute (NCI) have identified a promising new way to stop dangerous clots before they spiral out of control, without increasing
Primary mediastinal B-cell lymphoma (PMBCL) is a non-Hodgkin lymphoma that accounts for 5-7% of all aggressive lymphomas. Diagnosing PMBCL can be challenging as the features overlap with diffuse large B-cell lymphoma (DLBCL), another type of non-Hodgkin lymphoma. These two lymphomas respond
Researchers at the National Cancer Institute (NCI) have developed a diagnostic assay that detects sequence-specific (viral) RNA. This technology describes an RNase-H-assisted detection assay for RNA (RADAR) that is rapid, inexpensive, and highly sequence-specific. There is a great need for this
The Maryland Department of Economic Development just released a great new guide to technology transfer in Maryland. Maryland is home to 78 federal laboratories, including 27 Institutes/Centers from the National Institutes of Health (NIH) and is filled with excellent partnering opportunities. This